Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior. Chiodin G, Allen JD, Bryant DJ, Rock P, et al. Blood 2021;138:1570-1582.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chiodin G, Allen JD, Bryant DJ, Rock P, et al. Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior. Blood 2021;138:1570-1582.
PMID: 34424958